Residential school student dies, parents suspect foul play

DHNS
September 18, 2017

Davangere, Sept 18: A Class 7 student of Morarji Desai residential school in Kariganur near Basavapatna in the district died at McGann Hospital in Shivamogga on Sunday.

However, her parents have lodged a complaint with the police, raising doubts over the cause of the her death.

The deceased has been identified as Aishwarya. According to the complaint lodged by the girl’s father Rangappa, he got a call from the school on September 12, that his daughter was ill.

“I went to the school on September 13 and found that Aishwarya’s leg was swollen. We shifted her to the district hospital in Davanagere and then to McGann Hospital in Shivamogga. She died on Sunday.

“There are suspicions about the cause of her death,” the complaint said.

Dr Bhimashankar Guled, Superintendent of Police, Davangere, told DH that the exact cause of the girl’s death would be known after receiving the post-mortem report.

Deputy director of Social Welfare department Kumara Hanumanthappa said that Aishwarya had injured her leg after she fell down on the school premises on September 10.

Comments

Unknown
 - 
Monday, 18 Sep 2017

obviously foul play is there. No doubt

Danish
 - 
Monday, 18 Sep 2017

Sad incident. RIP. probe needed

Hari
 - 
Monday, 18 Sep 2017

Should have proper probe

Sangeeth
 - 
Monday, 18 Sep 2017

If anything is there, the management team wont reveal. Because it affect their reputation and admission.

Suresh
 - 
Monday, 18 Sep 2017

Dont know what happened, still i feel unusal thing. There are many cases reported recently regarding failure or unwanted action from school authority. 

Kumar
 - 
Monday, 18 Sep 2017

No doubt. something happened in school and they didnt reveal fully to parents

Ganesh
 - 
Monday, 18 Sep 2017

I feel SOMETHING fishy 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Belagavi, Apr 30: Police Sub-Inspector attached to Sadalaga Police Station Anil Kumbar was suspended on Wednesday pending inquiry for negligence and misbehavior in Examba incident, Superintendent of Police Laxman Nimbargi said.

According to him, the PSI was suspended as he misbehaved with Sachin Sawant a Centeral Reserve Police Force (CRPF) Cobra Commando on April 23 at his native village Yakshamba village and arrested him on charges of not wearing mask. On scuffle with the constable the commando was handcuffed and chained at Sadalaga police station.

Sachin Sawant was sent to Hindlaga Jail by the Court and was released on conditional bail on Tuesday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 10,2020

Bengaluru, Jul 10: The Karnataka cabinet gave its approval for "The Karnataka Contingency Fund (Amendment) Bill, 2020" to enhance the contingency fund limit to Rs 500 crore in the wake of the COVID-19 pandemic.

This will be an ordinance making one time enhancement in the limit as the government needs money to make payments immediately, Law and Parliamentary Affairs Minister JC Madhuswamy told reporters after a cabinet meeting.

Under the contingency fund, the government had room to spend up to Rs 80 crore without budget provision.

"...but this time due to COVID-19 as we had to give money to some sections that were in distress like barbers, flower and vegetable growers, taxi drivers, among others, we have decided to increase the limit to Rs 500 crore," Mr Madhuswamy said.

"As assembly was not in session and as we had to make payments to those in distress immediately, this decision has been taken," he added.

The cabinet today ratified the administrative approval given to carry out civil and electrical works to install medical gas pipeline with high flow oxygen system at district hospitals, taluk and community health centres coming under Health and Family welfare department in view of COVID-19.

The minister said about Rs 207 crore is being approved for this purpose.

It also ratified procurement of medical equipment and furniture for public healthcare institutions of the health and family welfare department worth Rs 81.99 crore.

According to the minister, the cabinet has decided to bring in an amendment to section 9 of the Lokayukta act, which mandates that the preliminary inquiry contemplated by Lokayukta or Upalokayuta should be completed in 90 days and charge sheeting should be completed within six months.

Noting that at the Agricultural Produce Market Committee (APMC) cess was being collected, he said as the government had brought in an amendment to the APMC act, there was demand to reduce the market cess. "So we have reduced it from 1.5 per cent to one per cent."

Approval has also been given by the cabinet to bring Karnataka Vidyuth Kharkane (KAVIKA) and Mysore Electrical Industries (MEI), which are presently under the control of Commerce and Industries department, under administrative control of the energy department.

Other decisions taken by the cabibinet include deployment and implementation of "e-procurement 2.0" project on PPP at a cost of Rs 184.37 crore and ratification of the action taken to issue orders on March 24 to release interest free loan of Rs 2,500 crore to ESCOMs for payment of outstanding power purchase dues to generating companies.

The cabinet also gave administrative approval for setting up of an Indian Institute of Information technology at Raichur.

"Under this, we are committed to provide Rs 44.8 crore in four years for infrastructure," the minister added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.